These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11380435)

  • 1. Potential strategies for the treatment of plasma exchange-resistant thrombotic thrombocytopenic purpura.
    Quintini G; Barbera V; Iannitto E; Mariani G
    Br J Haematol; 2001 May; 113(2):560-2. PubMed ID: 11380435
    [No Abstract]   [Full Text] [Related]  

  • 2. Splenectomy: the last option of immunosuppressive therapy in patients with chronic or relapsing idiopathic thrombotic thrombocytopenic purpura?
    Modic M; Cernelc P; Zver S
    Transplant Proc; 2002 Nov; 34(7):2953-4. PubMed ID: 12431670
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with cyclosporine of thrombotic thrombocytopenic purpura refractory to corticosteroids and plasma exchange.
    Honda K; Hidaka S; Kobayashi S
    Ther Apher Dial; 2011 Apr; 15(2):215-7. PubMed ID: 21426520
    [No Abstract]   [Full Text] [Related]  

  • 4. [Response to rituximab in two patients with plasma exchange-refractory thrombotic thrombocytopenic purpura].
    Pérez A; Sancho JM; Grífols JR; Ribera JM
    Med Clin (Barc); 2011 Jun; 137(3):139-40. PubMed ID: 21074219
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura. II. Principles of therapy and guidelines for management.
    Sills RH
    Am J Pediatr Hematol Oncol; 1984; 6(4):431-9. PubMed ID: 6398631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombotic thrombocytopenic purpura, systemic lupus erythematosus and rescue treatment with cyclophosphamide].
    Ramírez Duque N; García Morillo JS; Andreu Alvarez J; Martino Galiana ML
    Rev Clin Esp; 2005 Oct; 205(10):520-2. PubMed ID: 16238970
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression.
    Hess DC; Sethi K; Awad E
    J Rheumatol; 1992 Sep; 19(9):1474-8. PubMed ID: 1433020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral nephrectomy for treatment resistant systemic lupus erythematosis and thrombotic thrombocytopenic purpura: a case report.
    Feldman M; Bruno T; Chong YC; Borstad G; Wild C; Lopez JD; George JN
    Am J Hematol; 2007 Jun; 82(6):496-7. PubMed ID: 17154378
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral cyclophosphamide for refractory or relapsing thrombotic thrombocytopenic purpura (TTP).
    Hertzberg MS; Koutts J
    Aust N Z J Med; 1997 Aug; 27(4):439. PubMed ID: 9448886
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of thrombotic thrombocytopenic purpura with plasma infusions and cyclophosphamide.
    Wallach HW; Oren ME; Herskowitz A
    South Med J; 1979 Oct; 72(10):1346-7. PubMed ID: 573498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide.
    Fakhouri F; Teixeira L; Delarue R; Grünfeld JP; Veyradier A
    Ann Intern Med; 2004 Feb; 140(4):314-5. PubMed ID: 14970167
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases.
    Pérez-Sánchez I; Anguita J; Pintado T
    Ann Hematol; 1999 Jun; 78(6):285-7. PubMed ID: 10422632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory thrombotic thrombocytopenic purpura treated with cyclosporine.
    Bachman WR; Brennan JK
    Am J Hematol; 1996 Jan; 51(1):93-4. PubMed ID: 8571946
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura.
    Ding J; Baer MR; Hess JR; Zimrin AB
    Am J Hematol; 2018 Mar; 93(3):E77-E79. PubMed ID: 29247542
    [No Abstract]   [Full Text] [Related]  

  • 15. Unsuccessful treatment of resistant thrombotic thrombocytopenic purpura with prostacyclin.
    Salvi F; Baraldi A; Allione B; Santi R; Inverardi D; Levis A
    Haematologica; 2000 Dec; 85(12):1329-30. PubMed ID: 11114144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of idiopathic thrombopenic purpura].
    Mueller-Eckhardt C
    Dtsch Med Wochenschr; 1970 Nov; 95(46):2342-4. PubMed ID: 5529651
    [No Abstract]   [Full Text] [Related]  

  • 17. A successful combination of plasma exchange and intravenous cyclophosphamide in a patient with a refractory thrombotic thrombocytopenic purpura.
    Zappasodi P; Corso A; Castagnola C; Tajana M; Lunghi M; Bernasconi C
    Eur J Haematol; 1999 Oct; 63(4):278-9. PubMed ID: 10530421
    [No Abstract]   [Full Text] [Related]  

  • 18. Does cyclophosphamide benefit relapsing thrombotic thrombocytopenic purpura?
    Agarwal V; Sharma BL; Aggarwal A; Misra R
    J Assoc Physicians India; 2002 Nov; 50():1440-2. PubMed ID: 12583481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NICE guidance on caplacizumab for treating acute acquired thrombotic thrombocytopenia purpura.
    Hughes M; Prescott C; Elliott N; Adler AI
    Lancet Haematol; 2021 Jan; 8(1):e14-e15. PubMed ID: 33357475
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus.
    Niaz FA; Aleem A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):109-12. PubMed ID: 20061703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.